U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > Mesothelioma, malignant

Summary

Malignant mesothelioma is an aggressive neoplasm of the serosal lining of the chest etiologically linked to asbestos. It is diagnosed in approximately 2,000 to 3,000 individuals annually in the United States, most of whom die within 2 years of diagnosis (summary by Bott et al., 2011). See also 614327 for a tumor predisposition syndrome that may contribute to the development of malignant mesothelioma upon asbestos exposure and is caused by germline mutation in the BAP1 gene (603089) on chromosome 3p21. [from OMIM]

Available tests

52 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Genes See tests for all associated and related genes

  • Also known as: CARMEN, CIPER, CLAP, IMD37, c-E10, mE10, BCL10
    Summary: BCL10 immune signaling adaptor

  • Also known as: AWT1, GUD, NPHS4, WAGR, WIT-2, WT-1, WT33, WT1
    Summary: WT1 transcription factor

Clinical features

Help

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.